Search Saint Luke's

Sally was working when she felt a pain in her chest so bad it felt like someone punched her.

CHILLICOTHE, Mo.

After dealing with a scary episode and overcoming her own heart issues, Dixie started an effort to educate the women in her life about heart attacks.

Lung Cancer
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (SigVie-003). 

After a serious crash in rural Missouri, Mark Carr felt at ease in the hands of the Saint Luke's Hospital of Kansas City trauma team.

Breast Cancer

A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-high or High risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.

Saint Luke’s Cancer Institute genetic counselors help patients assess and manage future cancer risks, especially individuals who may have a hereditary cancer syndrome.

The Cardiology Critical Care rotation involves the provision of pharmaceutical care for those patients in the Coronary Intensive Care Unit (CICU) as well as the Advanced Heart Failure/Heart Transplant Unit (H5 South)